The window for postexposure prophylaxis against Covid-19 is narrow. 1-3 Therapy that is initiated up to 4 days after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is early ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Hydroxychloroquine did not prevent illness similar to, ...

Hydroxychloroquine doesn’t protect against COVID-19 in people who have come in contact with the SARS-CoV-2 virus at home or work, according to a randomized, placebo-controlled trial published this ...

Over 69.41 million people around the world have been infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, of these, over 1.49 million people have lost their lives. The ...

EAST BRUNSWICK N.J.--(BUSINESS WIRE)--Rising Pharma Holdings, Inc., operating as Rising Pharmaceuticals, today announced the donation of Hydroxychloroquine tablets in support of a Phase 2 randomized ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Many planned randomized trials to test the efficacy of hydroxychloroquine or related drugs for ...

NEW YORK--(BUSINESS WIRE)--Hydroxychloroquine, a widely available and inexpensive drug initially used for malaria as well as lupus and rheumatoid arthritis, has been the subject of intense medical and ...

Researchers found that taking hydroxychloroquine once or twice weekly did not prevent the development of COVID-19 in health care workers better than the placebo. University of Minnesota Medical School ...

Hydroxychloroquine, the anti-malarial drug touted and previously taken by President Donald Trump to fight coronavirus, has fallen out of favor and public view as studies — like one halted Friday — ...

Patients were then assigned to receive either placebo (n= 354) or hydroxychloroquine 800mg once, followed in 6-8 hours by 600mg, and then 600mg once daily for 4 consecutive days. The use of ...